Explore the Federal Circuit's exclusive authority over pharmaceutical patent cases, covering key precedents like Mylan, Hatch-Waxman disputes, and the impact on generic drug timelines.
Nov, 26 2025
Dec, 9 2025
Dec, 4 2025
Jul, 31 2026
Jul, 14 2026